Accelerating Parkinson’s Disease drug development with federated learning approaches

Accelerating Parkinson’s Disease drug development with federated learning approaches

Abstract Parkinson’s Disease is a progressive neurodegenerative disorder afflicting almost 12 million people. Increased understanding of its complex and heterogenous disease pathology, etiology and symptom manifestations has resulted in the need to design, capture and interrogate substantial clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: Amit Khanna, Jamie Adams, Chrystalina Antoniades, Bastiaan R. Bloem, Camille Carroll, Jesse Cedarbaum, Joshua Cosman, David T. Dexter, Marissa F. Dockendorf, Jeremy Edgerton, Laura Gaetano, Erkuden Goikoetxea, Derek Hill, Fay Horak, Elena S. Izmailova, Tairmae Kangarloo, Dina Katabi, Catherine Kopil, Michael Lindemann, Jennifer Mammen, Kenneth Marek, Kevin McFarthing, Anat Mirelman, Martijn Muller, Gennaro Pagano, M. Judith Peterschmitt, Jie Ren, Lynn Rochester, Sakshi Sardar, Andrew Siderowf, Tanya Simuni, Diane Stephenson, Christine Swanson-Fischer, John A. Wagner, Graham B. Jones
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-024-00837-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41531-024-00837-5

Similar Items